Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Kidney Function and Risk Factors in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Undergoing 177Lutetium-PSMA Radioligand Therapy: a Prospective Observational Study - KiRi-Trial

Hannah Schaefer · 2024
ClinicalTrials.gov · Datasets · License: Public Domain · 2024
Open Source ↗
kidney disease, radiation nephropathy, metastatic castrate resistant prostate cancer (mcrpc), mcrpc, 177lutetium, 177lu-psma, radioligand therapy, observational
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1032960
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.